April 2023
Volume 64, Issue 4
Open Access
Cornea  |   April 2023
On the Mechanical Roles of Glycosaminoglycans in the Tensile Properties of Porcine Corneal Stroma
Author Affiliations & Notes
  • Hamed Hatami-Marbini
    Computational Biomechanics Research Laboratory, Mechanical and Industrial Engineering Department, University of Illinois at Chicago, Chicago, Illinois, United States
  • Correspondence: Hamed Hatami-Marbini, Computational Biomechanics Research Laboratory, Mechanical and Industrial Engineering Department, University of Illinois at Chicago, 2039 Engineering Research Facility, 842 West Taylor Street, Chicago, IL 60607, USA; hatami@uic.edu
Investigative Ophthalmology & Visual Science April 2023, Vol.64, 3. doi:https://doi.org/10.1167/iovs.64.4.3
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hamed Hatami-Marbini; On the Mechanical Roles of Glycosaminoglycans in the Tensile Properties of Porcine Corneal Stroma. Invest. Ophthalmol. Vis. Sci. 2023;64(4):3. https://doi.org/10.1167/iovs.64.4.3.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The cornea is primarily composed of collagen fibrils that are embedded in a ground substance rich in proteoglycans and other glycoproteins. It is known that glycosaminoglycan (GAG) side chains of proteoglycans form anti-parallel duplexes between collagen fibrils. The present work was done in order to investigate the mechanical function of GAGs in defining the tensile properties of porcine corneal stroma.

Methods: Porcine corneal stromal strips dissected from the nasal–temporal direction were divided into control, buffer-treated, and enzyme-treated groups. The samples in the control group were used immediately after dissection. However, the buffer-treated and enzyme-treated samples were, respectively, incubated for 18 hours at 37°C in a buffer solution made up of 100-mM sodium acetate at pH 6.0 or in an enzyme solution containing keratanase II. The Blyscan assay was used to quantify the total GAG content and assess GAG depletion in the samples treated with the enzyme and buffer solutions. Uniaxial tensile tests were also performed to determine the effect of GAG removal on mechanical properties of the cornea.

Results: The GAG content in enzyme-treated samples was significantly lower than that of the normal and buffer-treated specimens (P < 0.05). Moreover, GAG-depleted strips showed significantly softer mechanical responses in comparison with the control and buffer samples (P < 0.05).

Conclusions: Removing GAGs from the corneal extracellular matrix led to significant tensile property reduction; supporting the hypothesis that there exists a strong correlation between the GAG content and mechanical properties of the corneal stroma.

The cornea is a transparent tissue that covers the front of the eye; and serves as a protective layer for the delicate internal contents of the eye. In addition, the cornea has a central role in proper vision because of its unique optical properties. It transmits over 95% of incoming light, has a refractive power of about 43 diopters, and is responsible for most of the refractive power in the eye. These unique optical properties are primarily because of the exceptionally organized microstructure of the corneal extracellular matrix (i.e., stroma). 
The mechanical and physical properties of the cornea are primarily governed by the stroma, a mesenchymal connective tissue making up approximately 90% of the total corneal thickness. The corneal stromal collagen fibrils are embedded in parallel-to-the-surface lamellae. The fibrils are spaced apart by a ground substance rich in proteoglycans (PGs) and other glycoproteins.1 The PGs, composed of a core protein to which glycosaminoglycans (GAGs) are attached, bind at specific sites along the collagen fibrils. GAGs are negatively charged linear complex molecules that are essential for regulating corneal collagen fibrillar assembly and organization.2 The mechanical role of GAGs in defining corneal mechanical properties is not yet fully understood. 
The syntheses and sulfation of GAGs occur inside the Golgi apparatus.3 Five classes of GAGs, i.e., chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate (KS), heparan sulfate, and hyaluronic acid, are found in mammalian tissues: Except for hyaluronic acid, which is a non-sulfated GAG, the others are attached to a core protein and form PGs. GAGs play different functions in the extracellular matrix of soft tissues. For example, they are important in a variety of cell functions such as adhesion, proliferation, motility, and differentiation.48 They also play a role in growth factor signaling, the mechanical properties of a tissue, and regulating the collagen structure.9,10 PGs and their GAG side chains, because of their regulatory effects on the diameter and specific organization of collagen fibrils, are important for the unique microstructure and transparency of the corneal extracellular matrix.1115 Thus, any changes in the GAG content and composition are expected to influence corneal mechanical properties. 
The major sulfated GAGs in the cornea are CS, DS, and KS, which appear as side chains of decorin, biglycan, lumican, keratocan, fibromodulin, and mimecan PGs.1620 KS, the predominant corneal GAG, is composed of repeating disaccharides consisting of galactose (Gal) and N-acetylglucosamine.21 The densities and ratios of KS, CS, and DS are important in defining the corneal microstructure and subsequently its proper optical and mechanical functions. For example, the increase in collagen interfibrillar spacing and disorganization of collagen regular packing during corneal wound healing and in scar tissue are believed to be due to raised levels of CS and DS and a reduction of KS.12,2224 Macular corneal dystrophy is a heritable disease condition in which the cornea becomes cloudy because individuals are unable to produce KS.25,26 Furthermore, the deficiency of GAG-degradative enzymes in mucopolysaccharidoses, such as Hurler and Scheie syndromes, causes an accumulation of DS resulting in clouding of the cornea and loss of the visual acuity.27 Finally, the loss of tensile strength and a reduction in GAG density have been reported in keratoconus.2831 Thus, it could be hypothesized that GAG content reduction could lead to corneal mechanical property weakening. The primary objective of the present study was to test this hypothesis by removing GAGs enzymatically and quantifying their effects on corneal tensile properties. 
Methods
Tissue Preparation and GAG Removal Protocol
The eyes of 6- to 8-month-old pigs were obtained from a slaughterhouse shortly after the animals were slaughtered. All samples were used immediately after they were brought to the laboratory. The epithelium was scraped off with the blunt side of a blade, and corneal scleral rings were prepared from the eyes. Then, a custom-made cutting device was used to dissect rectangular corneal strips of 5-mm width from the center of the samples in the nasal–temporal direction. The strips were dissected from the same direction so that corneal anisotropic properties would not affect the measurements.32,33 The samples were used for both mechanical tests and GAG content studies. A digital pachymeter (DGH Technology, Inc., Exton, PA, USA) and a digital caliper (Mitutoyo Corporation, Kawasaki, Japan) were used to measure the thickness and width of the specimens, respectively. The specimens were divided into (1) a control group, (2) a buffer-treated group, and (3) an enzyme-treated group. The buffer solution was made up of 100-mM sodium acetate at pH 6.0, and the enzyme solution contained Keratanase II truncated sequence from Bacillus circulans (GlycoFineChem, Wellington, New Zealand) at 0.1 U/mL. The samples were incubated in the buffer solution (buffer group) or in the enzyme solution (enzyme group) for 18 hours at 37°C. After incubation, the samples were rinsed in PBS solution. The buffer and enzyme group samples were completely dried for 24 hours in a desiccator before incubation. The samples in the control group were used immediately after dissection. 
GAG Quantification
The GAG quantification was performed using the Blyscan assay (Biocolor Ltd., Carrickfergus, Northern Ireland). For this purpose, the specimens were first dried for 24 hours in a desiccator to obtain their dry weight. Then, they were incubated in buffer solution or enzyme solution for 18 hours. The samples in the control group were immersed in PBS until they reached approximately their after-dissection thickness. Furthermore, the samples in the buffer and enzyme groups were washed in PBS after treatment. The Blyscan assay is a quantitative dye-binding method for the analysis of GAGs in which test materials are assayed following papain extraction from the biological tissue. Thus, the corneal specimens in the control group (n = 8), buffer group (n = 8), and enzyme group (n = 8) were immersed in papain solution (P3125; Sigma-Aldrich, St. Louis, MO, USA) for 18 hours at 60°C. The protocol described in the literature was then followed to obtain the GAG content as µg/mg dry tissue.34,35 
Mechanical Tests
An RSA-G2 machine (TA Instruments, New Castle, DE, USA) was used to measure the mechanical tensile response of the control (n = 10), buffer-treated (n = 10), and enzyme-treated (n = 10) groups. The samples in the buffer and enzyme groups were initially dried for 24 hours, immersed in the buffer or enzyme solution for 18 hours, and finally washed in PBS. The strips were allowed to air dry until their thickness reached 700 µm (i.e., the in vivo thickness of porcine cornea)36,37 before they were mounted to the testing device. This was done in order to minimize the hydration effects on the mechanical measurements.32,38 In other words, all mechanical experiments were performed when the thickness of samples was 700 µm and their average hydration was about 3.85 mg water/mg dry weight.39 The strips were secured between grips of the RSA-G2 machine at a loading gap of about 7 mm. Sandpaper was used at the grips to increase friction and prevent any slippage. A tare load of about 20 to 30 mN was then applied in order to remove slack and determine the initial length (L0) of the samples.37 The samples were stretched to a strain of ε = 20% with a displacement rate of 2 mm/min. The engineering strain (ε) was defined as the change in the length between the grips divided by L0. The engineering tensile stress (σ) was calculated by dividing the measured force by the initial cross-sectional area of the strips. The experiments took about a minute to complete; thus, they were done in air.37 The thickness of a number of strips was measured after the experiments to confirm that no significant dehydration occurred. 
The tensile stress–strain curves were plotted and the maximum tensile stress and tangent modulus were computed to compare the mechanical response of different groups. The tangent modulus was taken as the slope of the tangent line to the stress–strain curves. The experimental data were reported as mean ± standard deviation. Furthermore, any statistically significant difference between groups was determined by performing an ANOVA with P = 0.05. Finally, the following equation was used to numerically represent the experimental measurements:32 
\begin{equation}\sigma = \alpha {\varepsilon ^\beta } + {\sigma _0}\end{equation}
(1)
where σ0 is the initial tensile stress, and α and β are the unknown parameters. The Levenberg–Marquardt algorithm was used to calculate the unknown constants by fitting the above numerical relation to the experimental stress–strain data. 
Results
The GAG contents of the control, buffer-treated, and enzyme-treated samples are given in Table 1. No significant difference was found between the GAG content of the buffer-treated and control samples (P = 0.9); however, the GAG content significantly decreased, about 80%, after treatment with the keratanase II enzyme. Figure 1 shows the tensile stress–strain response of GAG-depleted samples in comparison with the behavior of the buffer and control group strips. The solid lines in this figure depict the numerical curve fits. The means and standard deviations of the coefficients in Equation 1 are given in Table 2, and Figure 2 presents the maximum tensile stress and tangent modulus of the corneal strips. No significant difference was observed in the tensile properties of the control and buffer-treated samples; however, the maximum tensile stress and tangent modulus of corneal strips decreased significantly after incubation in the enzyme solution (P < 0.05). 
Table 1.
 
GAG Content of Control, Buffer-Treated, and Enzyme-Treated Corneal Samples Obtained From Blyscan Analysis
Table 1.
 
GAG Content of Control, Buffer-Treated, and Enzyme-Treated Corneal Samples Obtained From Blyscan Analysis
Figure 1.
 
A comparison of the stress–strain behavior of porcine corneal strips in the control, buffer-treated, and enzyme-treated groups. It can be seen that the buffer treatment had an insignificant effect on tensile response. Furthermore, the GAG-depleted strips had significantly softer responses compared to those of the buffer-treated and control samples. The solid lines represent the numerical fits of the average data, and error bars indicate ±1 SD.
Figure 1.
 
A comparison of the stress–strain behavior of porcine corneal strips in the control, buffer-treated, and enzyme-treated groups. It can be seen that the buffer treatment had an insignificant effect on tensile response. Furthermore, the GAG-depleted strips had significantly softer responses compared to those of the buffer-treated and control samples. The solid lines represent the numerical fits of the average data, and error bars indicate ±1 SD.
Table 2.
 
Means and SDs of Coefficients in Equation 1
Table 2.
 
Means and SDs of Coefficients in Equation 1
Figure 2.
 
Maximum tensile stress and tangent modulus of the control, buffer-treated, and enzyme-treated strips. The tensile properties of the strips after buffer treatment were similar to those of the control specimens. However, a significant amount of softening was found in the enzyme-treated specimens from which GAGs have been removed enzymatically (P < 0.05).
Figure 2.
 
Maximum tensile stress and tangent modulus of the control, buffer-treated, and enzyme-treated strips. The tensile properties of the strips after buffer treatment were similar to those of the control specimens. However, a significant amount of softening was found in the enzyme-treated specimens from which GAGs have been removed enzymatically (P < 0.05).
Discussion
The objective of the present work was to determine possible effects of GAGs on mechanical properties of the corneal stroma. For this purpose, we used keratanase II to remove GAGs from porcine corneal strips and performed uniaxial tensile experiments to quantify the mechanical response of GAG-depleted and normal corneal strips. GAGs are responsible for the maintenance of regular collagen interfibrillar spacing in corneal extracellular matrix and thus transparency of the cornea.4042 The three-dimensional electron microscopic reconstructions of the cornea showed that GAG chains from separate PGs joined together, forming anti-parallel duplexed associations between collagen fibrils.42 The absence of KS in a strain of mice with a targeted gene depletion caused significant alterations in the corneal collagen fibrillar architecture.43 Considering these previous observations, we hypothesized that GAGs could affect corneal mechanical properties. 
In the present study, keratanase II was used to remove KS from porcine corneal strips. The Blyscan analysis estimated an average GAG content of 50 µg/mg dry tissue for the porcine cornea, which is in agreement with a recent study using porcine lenticules.44 A similar amount of sulfated GAGs was also reported in bovine cornea.45 The amount of GAGs in human cornea was reported to be 34 to 65 µg/mg dry tissue.46,47 It is interesting to note here that the total sulfated polyanion content of the corneal stroma was proposed to be approximately constant in different species.48 
Previous studies have shown that KS comprises the majority of GAGs in human, bovine, and porcine corneal stroma. For example, KS is estimated to constitute about 65% of human corneal GAGs.4850 KS GAG chains are shorter, connecting neighboring collagen fibrils; CS and DS GAG chains are longer, interacting with several collagen fibrils.42 The present study showed that keratanase II enzyme removed about 80% of GAGs from samples. Although the overall density of sulfated GAGs (i.e., KS and CS/DS) is constant across the cornea, the ratio of KS GAGs and CS and DS GAGs is variable.51 For example, in both human and bovine corneas, KS is mainly present in the central region, and its density decreases toward the peripheral regions, where CS is predominantly found.51 Furthermore, DS is present throughout the bovine corneal stroma, but it is mainly found in the corneal limbus in humans.45 The dissimilarities in the location of specific GAGs are due to species differences and characterization methods used for their detection. 
Although factors such as age and breed of animals influence corneal tensile properties reported in different studies, our tensile measurements were in agreement with previous reports.52,53 Wollensak et al.52 found an average Young's modulus of 2.2 MPa at 8% strain for porcine corneas using a similar testing protocol. Furthermore, Hatami-Marbini and Jayaram53 found a tensile modulus of 2.57 ± 0.68 MPa at 8% strain when the average thickness of samples was 760 µm. In the present study, the tensile modulus of the control samples at 8% strain was 2.50 ± 1.01 MPa, which agrees very well with these previous reports. 
Figure 1 shows that GAG-depleted strips had significantly softer tensile properties compared to the control and buffer-treated specimens. The maximum tensile stress (0.55 ± 0.08 MPa) and tangent modulus (0.55 ± 0.08 MPa) of enzyme-treated strips were significantly lower than those of the control and buffer-treated strips. There are different reports in the literature about the effects of GAGs on the mechanical properties of soft tissues, suggesting that the mechanical role of GAGs is tissue dependent. In general, the mechanical response of tissues with low GAG contents, such as tendons and ligaments, was found to be independent of GAGs.54,55 However, GAGs were found to have a significant influence on the mechanical response of tissues with high GAG content, such as cartilage, aorta, and atrioventricular heart valve leaflets.5658 Despite this general trend, contrary results also exist. For example, Lujan et al.54 reported no change in the viscoelasticity of ligaments after GAG removal, but Hoffman et al.59 found a stiffness increase. Furthermore, the tensile response of the sclera remained unchanged or changed after GAG depletion depending on the testing protocol that was used.60,61 The present study showed that GAG digestion decreased the tensile stiffness and strength of porcine corneal stroma. This finding is consistent with the reduction in tensile properties of the cornea because of keratoconus, which incorporates a significant reduction in GAG concentration.2831 
PGs inside the corneal extracellular matrix are attached to collagen fibrils by their core proteins, and their GAG side chains form interfibrillar duplexes acting as spacers between adjacent fibrils.41,42,62 This means that the anti-parallel multiplexes formed by GAG chains behave as bridges and yardsticks between collagen fibrils holding them in place. Thus, GAGs are expected to modulate force transmission between collagen fibrils. The corneal stroma can be modeled as a composite material composed of reinforcing collagen fibrils in a PG matrix domain.63 In this model, GAG duplexes contribute to the stress transfer between the soft, compliant matrix and stiff collagen fibrils (Fig. 3). GAG–GAG bridges between collagen fibrils are prevalent in the corneal extracellular matrix because of the large concentration of PGs. However, GAG–GAG interactions are not covalent and are subject to constant formation and dissociation. When the density of GAGs is reduced because of enzymatic digestion (or a diseased condition), the probability of formation of GAG bridges is reduced (Fig. 3), which is why a significant reduction was found in the tensile properties of the enzyme-treated samples in comparison to the control and buffer-treated strips (Figs. 12). In other words, GAG removal reduced the strength of the matrix domain, which led to a reduction in the overall mechanical response of the corneal stroma. 
Figure 3.
 
A simplistic schematic plot for explaining the possible structural role of GAGs in corneal tensile properties. The corneal stroma can be considered as a composite material composed of reinforcing collagen fibrils that are placed in a PG matrix domain. In this model, GAG duplexes contribute to the stress transfer between the soft, compliant matrix and stiff collagen fibrils. The number of GAG bridges was significantly lower in samples of the enzyme-treated group, which is why they showed significantly softer tensile properties.
Figure 3.
 
A simplistic schematic plot for explaining the possible structural role of GAGs in corneal tensile properties. The corneal stroma can be considered as a composite material composed of reinforcing collagen fibrils that are placed in a PG matrix domain. In this model, GAG duplexes contribute to the stress transfer between the soft, compliant matrix and stiff collagen fibrils. The number of GAG bridges was significantly lower in samples of the enzyme-treated group, which is why they showed significantly softer tensile properties.
This work had a number of limitations. For example, the uniaxial tensile method, which does not represent natural loading conditions of the cornea, was used to characterize the mechanical response of the samples. Strip extensometry does not provide any information regarding corneal out-of-plane properties, which have been shown to be significantly different than the tensile properties.64 The use of porcine samples could be another drawback of the present work. Future studies are needed to determine whether GAGs have the same effects on the mechanical properties of human cornea, in which the amount of GAGs and the collagen fibril orientation differ. A simple mathematical formulation was used here to numerically represent the experimental measurements. Three-dimensional network models are expected to provide a better numerical explanation for the structural roles of GAGs.6567 A complete digestion of GAGs was not done in this work, so the remaining GAGs might have contributed to the reported tensile properties. Finally, the mechanical measurements and KS quantification studies were not performed on the same specimens. Despite these limitations, the present work successfully showed that depleting GAGs from the corneal strips led to significant softening of their tensile behavior. This is an important finding; although it is well established that GAGs form side-by-side bridges between collagen fibrils in the corneal stroma, to the best of the author's knowledge there has not been any previous experimental study characterizing their role in defining the mechanical properties of the cornea. The experimental findings of this research may assist researchers to explain the changes in mechanical properties of the keratoconic cornea in terms of the significant GAG density reduction observed in this disease. 
Acknowledgments
The author thanks members of the Computational Biomechanics Research Laboratory at the University of Illinois at Chicago for assisting in conducting this research. 
Supported in part by a grant from the National Institutes of Health (NIH-R21EY030264). 
Disclosure: H. Hatami-Marbini, None 
References
Maurice DM. The structure and transparency of the cornea. J Physiol. 1957; 136: 263. [CrossRef] [PubMed]
Scott JE. Proteoglycan–fibrillar collagen interactions. Biochem J. 1988; 252: 313–323. [CrossRef] [PubMed]
Hassell JR, Kimura JH, Hascall VC. Proteoglycan core protein families. Annu Rev Biochem. 1986; 55: 539–567. [CrossRef] [PubMed]
Abatangelo G, Cortivo R, Martelli M, Vecchia P. Cell detachment mediated by hyaluronic acid. Exp Cell Res. 1982; 137: 73–78. [CrossRef] [PubMed]
Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977; 265: 625–626. [CrossRef] [PubMed]
Matuoka K, Mitsui Y. Involvement of cell surface heparan sulfate in the density-dependent inhibition of cell proliferation. Cell Struct Funct. 1981; 6: 23–33. [CrossRef]
Toole BP. Glycosaminoglycans in morphogenesis. In: Hay ED, ed. Cell Biology of Extracellular Matrix. Cham: Springer; 1981: 259–294.
Toole BP, Trelstad RL. Hyaluronate production and removal during corneal development in the chick. Dev Biol. 1971; 26: 28–35. [CrossRef] [PubMed]
Sodhi H, Panitch A. Glycosaminoglycans in tissue engineering: a review. Biomolecules. 2020; 11: 29. [CrossRef] [PubMed]
Cavalcante FSA, Ito S, Brewer K, et al. Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol. 2005; 98: 672–679. [CrossRef] [PubMed]
Benedek GB. Theory of transparency of the eye. Appl Opt. 1971; 10: 459–473. [CrossRef] [PubMed]
Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys. 1983; 222: 362–369. [CrossRef] [PubMed]
Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res. 1993; 56: 635–648. [CrossRef] [PubMed]
Scott J, Haigh M. ‘Small’–proteoglycan:collagen interactions: keratan sulphate proteoglycan associates with rabbit corneal collagen fibrils at the ‘a’ and ‘c’ bands. Biosci Rep. 1985; 5: 765–774. [CrossRef] [PubMed]
Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 2010; 91: 326–335. [CrossRef] [PubMed]
Li W, Vergnes J-P, Cornuet PK, Hassell JR. cDNA clone to chick corneal chondroitin/dermatan sulfate proteoglycan reveals identity to decorin. Arch Biochem Biophys. 1992; 296: 190–197. [CrossRef] [PubMed]
Corpuz LM, Funderburgh JL, Funderburgh ML, Bottomley GS, Prakash S, Conrad GW. Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J Biol Chem. 1996; 271: 9759–9763. [CrossRef] [PubMed]
Funderburgh JL, Hevelone ND, Roth MR, et al. Decorin and biglycan of normal and pathologic human corneas. Invest Ophthalmol Vis Sci. 1998; 39: 1957–1964. [PubMed]
Blochberger TC, Vergnes J-P, Hempel J, Hassell J. cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem. 1992; 267: 347–352. [CrossRef] [PubMed]
Chen S, Oldberg A, Chakravarti S, Birk DE. Fibromodulin regulates collagen fibrillogenesis during peripheral corneal development. Dev Dyn. 2010; 239: 844–854. [CrossRef] [PubMed]
Quantock AJ, Young RD, Akama TO. Structural and biochemical aspects of keratan sulphate in the cornea. Cell Mol Life Sci. 2010; 67: 891–906. [CrossRef] [PubMed]
Cintron C, Gregory J, Damle S, Kublin C. Biochemical analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci. 1990; 31: 1975–1981. [PubMed]
Anseth A. Studies on corneal polysaccharides: VIII. Changes in the glycosaminoglycans in some human corneal disorders. Exp Eye Res. 1969; 8: 438–441. [CrossRef] [PubMed]
Funderburgh JL, Chandler J. Proteoglycans of rabbit corneas with nonperforating wounds. Invest Ophthalmol Vis Sci. 1989; 30: 435–442. [PubMed]
Hassell JR, Newsome DA, Krachmer JH, Rodrigues MM. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc Natl Acad Sci USA. 1980; 77: 3705–3709. [CrossRef] [PubMed]
Nakazawa K, Hassell J, Hascall V, Lohmander L, Newsome D, Krachmer J. Defective processing of keratan sulfate in macular corneal dystrophy. J Biol Chem. 1984; 259: 13751–13757. [CrossRef] [PubMed]
Huang Y, Bron A, Meek K, Vellodi A, McDonald B. Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. Exp Eye Res. 1996; 62: 377–388. [CrossRef] [PubMed]
Funderburgh JL, Funderburgh ML, Rodrigues MM, Krachmer JH, Conrad GW. Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases. Invest Ophthalmol Vis Sci. 1990; 31: 419–428. [PubMed]
García B, García-Suárez O, Merayo-Lloves J, et al. Differential expression of proteoglycans by corneal stromal cells in keratoconus. Invest Ophthalmol Vis Sci. 2016; 57: 2618–2628. [CrossRef] [PubMed]
Chaerkady R, Shao H, Scott S-G, Pandey A, Jun AS, Chakravarti S. The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration. J Proteomics. 2013; 87: 122–131. [CrossRef] [PubMed]
Andreassen TT, Simonsen AH, Oxlund H. Biomechanical properties of keratoconus and normal corneas. Exp Eye Res. 1980; 31: 435–441. [CrossRef] [PubMed]
Hatami-Marbini H, Rahimi A. The relation between hydration and mechanical behavior of bovine cornea in tension. J Mech Behav Biomed Mater. 2014; 36: 90–97. [CrossRef] [PubMed]
Elsheikh A, Alhasso D. Mechanical anisotropy of porcine cornea and correlation with stromal microstructure. Exp Eye Res. 2009; 88: 1084–1091. [CrossRef] [PubMed]
Boubriak O, Urban J, Bron A. Differential effects of aging on transport properties of anterior and posterior human sclera. Exp Eye Res. 2003; 76: 701–713. [CrossRef] [PubMed]
Hatami-Marbini H, Pachenari M. The contribution of sGAGs to stress-controlled tensile response of posterior porcine sclera. PLoS One. 2020; 15: e0227856. [CrossRef] [PubMed]
Faber C, Scherfig E, Prause JU, Sørensen KE. Corneal thickness in pigs measured by ultrasound pachymetry in vivo. Scand J Lab Anim Sci. 2008; 35: 39–43.
Hatami-Marbini H, Jayaram SM. Effect of UVA/riboflavin collagen crosslinking on biomechanics of artificially swollen corneas. Invest Ophthalmol Vis Sci. 2018; 59: 764–770. [CrossRef] [PubMed]
Hatami-Marbini H, Etebu E. Hydration dependent biomechanical properties of the corneal stroma. Exp Eye Res. 2013; 116: 47–54. [CrossRef] [PubMed]
Hatami-Marbini H, Etebu E, Rahimi A. Swelling pressure and hydration behavior of porcine corneal stroma. Curr Eye Res. 2013; 38: 1124–1132. [CrossRef] [PubMed]
Maurice DM. Clinical physiology of the cornea. Int Ophthalmol Clin. 1962; 2: 561–572. [CrossRef] [PubMed]
Müller LJ, Pels E, Schurmans LRHM, Vrensen GFJM. A new three-dimensional model of the organization of proteoglycans and collagen fibrils in the human corneal stroma. Exp Eye Res. 2004; 78: 493–501. [CrossRef] [PubMed]
Lewis PN, Pinali C, Young RD, Meek KM, Quantock AJ, Knupp C. Structural interactions between collagen and proteoglycans are elucidated by three-dimensional electron tomography of bovine cornea. Structure. 2010; 18: 239–245. [CrossRef] [PubMed]
Hayashida Y, Akama TO, Beecher N, et al. Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase. Proc Natl Acad Sci USA. 2006; 103: 13333–13338. [CrossRef] [PubMed]
Fernández-Pérez J, Madden PW, Brady RT, Nowlan PF, Ahearne M. The effect of prior long-term recellularization with keratocytes of decellularized porcine corneas implanted in a rabbit anterior lamellar keratoplasty model. PLoS One. 2021; 16: e0245406. [CrossRef] [PubMed]
Ho LT, Harris AM, Tanioka H, et al. A comparison of glycosaminoglycan distributions, keratan sulphate sulphation patterns and collagen fibril architecture from central to peripheral regions of the bovine cornea. Matrix Biol. 2014; 38: 59–68. [CrossRef] [PubMed]
Pacella E, Pacella F, De Paolis G, et al. Glycosaminoglycans in the human cornea: age-related changes. Ophthalmol Eye Dis. 2015; 7: 1–5. [CrossRef] [PubMed]
Plaas AH, West LA, Thonar EJ, et al. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy. J Biol Chem. 2001; 276: 39788–39796. [CrossRef] [PubMed]
Scott JE, Bosworth TR. A comparative biochemical and ultrastructural study of proteoglycan-collagen interactions in corneal stroma. Functional and metabolic implications. Biochem J. 1990; 270: 491–497. [CrossRef] [PubMed]
Bettelheim FA, Goetz D. Distribution of hexosamines in bovine cornea. Invest Ophthalmol Vis Sci. 1976; 15: 301–304.
Gipson IK, Joyce NC, Zieske JD. The anatomy and cell biology of the human cornea, limbus, conjunctiva, and adnexa. In: Foster CS, Azar DT, Dohlman CH, eds. Smolin and Thoft's The Cornea: Scientific Foundation and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 1–36.
Borcherding MS, Blacik LJ, Sittig RA, Bizzell JW, Breen M, Weinstein HG. Proteoglycans and collagen fibre organization in human corneoscleral tissue. Exp Eye Res. 1975; 21: 59–70. [CrossRef] [PubMed]
Wollensak G, Spoerl E, Seiler T. Stress–strain measurements of human and porcine corneas after riboflavin–ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003; 29: 1780–1785. [CrossRef] [PubMed]
Hatami-Marbini H, Jayaram SM. Relationship between initial corneal hydration and stiffening effects of corneal crosslinking treatment. J Cataract Refract Surg. 2018; 44: 756–764. [CrossRef] [PubMed]
Lujan TJ, Underwood CJ, Henninger HB, Thompson BM, Weiss JA. Effect of dermatan sulfate glycosaminoglycans on the quasi-static material properties of the human medial collateral ligament. J Orthop Res. 2007; 25: 894–903. [CrossRef] [PubMed]
Fessel G, Snedeker JG. Evidence against proteoglycan mediated collagen fibril load transmission and dynamic viscoelasticity in tendon. Matrix Biol. 2009; 28: 503–510. [CrossRef] [PubMed]
Schmidt MB, Mow VC, Chun LE, Eyre DR. Effects of proteoglycan extraction on the tensile behavior of articular cartilage. J Orthop Res. 1990; 8: 353–363. [CrossRef] [PubMed]
Hoffman A, Grande L, Park J. Sequential enzymolysis of human aorta and resultant stress-strain behavior. Biomater Med Devices Artif Organs. 1977; 5: 121–145. [PubMed]
Eckert CE, Fan R, Mikulis B, et al. On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomater. 2013; 9: 4653–4660. [CrossRef] [PubMed]
Hoffman A, Park J, Abrahamson J. Sequential enzymolysis of ligament and resultant stress-strain behavior. Biomater Med Devices Artif Organs. 1973; 1: 453–467. [CrossRef] [PubMed]
Hatami-Marbini H, Pachenari M. On influence of sulfated glycosaminoglycans on tensile properties of posterior sclera. Mech Soft Mater. 2020; 2: 10. [CrossRef]
Hatami-Marbini H, Pachenari M. Tensile viscoelastic properties of the sclera after glycosaminoglycan depletion. Curr Eye Res. 2021; 46: 1299–1308. [CrossRef] [PubMed]
Farrell RA, Hart R. On the theory of the spatial organization of macromolecules in connective tissue. Bull Math Biophys. 1969; 31: 727–760. [CrossRef] [PubMed]
Hatami-Marbini H, Rahimi A. Effects of bathing solution on tensile properties of the cornea. Exp Eye Res. 2014; 120: 103–108. [CrossRef] [PubMed]
Hatami-Marbini H, Etebu E. An experimental and theoretical analysis of unconfined compression of corneal stroma. J Biomech. 2013; 46: 1752–1758. [CrossRef] [PubMed]
Chen X, Chen D, Ban E, et al. Glycosaminoglycans modulate long-range mechanical communication between cells in collagen networks. Proc Natl Acad Sci USA. 2022; 119: e2116718119. [CrossRef] [PubMed]
Hatami-Marbini H, Rohanifar M. Mechanical response of composite fiber networks subjected to local contractile deformation. Int J Solids Struct. 2021; 228: 111045. [CrossRef]
Hatami-Marbini H. Nonaffine behavior of three-dimensional semiflexible polymer networks. Phys Rev E. 2016; 93: 042503. [CrossRef] [PubMed]
Figure 1.
 
A comparison of the stress–strain behavior of porcine corneal strips in the control, buffer-treated, and enzyme-treated groups. It can be seen that the buffer treatment had an insignificant effect on tensile response. Furthermore, the GAG-depleted strips had significantly softer responses compared to those of the buffer-treated and control samples. The solid lines represent the numerical fits of the average data, and error bars indicate ±1 SD.
Figure 1.
 
A comparison of the stress–strain behavior of porcine corneal strips in the control, buffer-treated, and enzyme-treated groups. It can be seen that the buffer treatment had an insignificant effect on tensile response. Furthermore, the GAG-depleted strips had significantly softer responses compared to those of the buffer-treated and control samples. The solid lines represent the numerical fits of the average data, and error bars indicate ±1 SD.
Figure 2.
 
Maximum tensile stress and tangent modulus of the control, buffer-treated, and enzyme-treated strips. The tensile properties of the strips after buffer treatment were similar to those of the control specimens. However, a significant amount of softening was found in the enzyme-treated specimens from which GAGs have been removed enzymatically (P < 0.05).
Figure 2.
 
Maximum tensile stress and tangent modulus of the control, buffer-treated, and enzyme-treated strips. The tensile properties of the strips after buffer treatment were similar to those of the control specimens. However, a significant amount of softening was found in the enzyme-treated specimens from which GAGs have been removed enzymatically (P < 0.05).
Figure 3.
 
A simplistic schematic plot for explaining the possible structural role of GAGs in corneal tensile properties. The corneal stroma can be considered as a composite material composed of reinforcing collagen fibrils that are placed in a PG matrix domain. In this model, GAG duplexes contribute to the stress transfer between the soft, compliant matrix and stiff collagen fibrils. The number of GAG bridges was significantly lower in samples of the enzyme-treated group, which is why they showed significantly softer tensile properties.
Figure 3.
 
A simplistic schematic plot for explaining the possible structural role of GAGs in corneal tensile properties. The corneal stroma can be considered as a composite material composed of reinforcing collagen fibrils that are placed in a PG matrix domain. In this model, GAG duplexes contribute to the stress transfer between the soft, compliant matrix and stiff collagen fibrils. The number of GAG bridges was significantly lower in samples of the enzyme-treated group, which is why they showed significantly softer tensile properties.
Table 1.
 
GAG Content of Control, Buffer-Treated, and Enzyme-Treated Corneal Samples Obtained From Blyscan Analysis
Table 1.
 
GAG Content of Control, Buffer-Treated, and Enzyme-Treated Corneal Samples Obtained From Blyscan Analysis
Table 2.
 
Means and SDs of Coefficients in Equation 1
Table 2.
 
Means and SDs of Coefficients in Equation 1
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×